BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 10728790)

  • 1. Hepatobiliary transport.
    Kullak-Ublick GA; Beuers U; Paumgartner G
    J Hepatol; 2000; 32(1 Suppl):3-18. PubMed ID: 10728790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis.
    Zollner G; Fickert P; Silbert D; Fuchsbichler A; Marschall HU; Zatloukal K; Denk H; Trauner M
    J Hepatol; 2003 Jun; 38(6):717-27. PubMed ID: 12763363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic cholestasis, causes and consequences for hepatobiliary transport.
    Jansen PL; Sturm E
    Liver Int; 2003 Oct; 23(5):315-22. PubMed ID: 14708891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
    Stieger B
    Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice.
    Elamiri A; Perwaiz S; Tuchweber B; Yousef IM
    Pharmacol Res; 2003 Nov; 48(5):467-72. PubMed ID: 12967592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
    Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
    Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic transport of bile salts.
    Kullak-Ublick GA; Stieger B; Hagenbuch B; Meier PJ
    Semin Liver Dis; 2000; 20(3):273-92. PubMed ID: 11076396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.
    Zollner G; Fickert P; Zenz R; Fuchsbichler A; Stumptner C; Kenner L; Ferenci P; Stauber RE; Krejs GJ; Denk H; Zatloukal K; Trauner M
    Hepatology; 2001 Mar; 33(3):633-46. PubMed ID: 11230744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile salt excretion in skate liver is mediated by a functional analog of Bsep/Spgp, the bile salt export pump.
    Ballatori N; Rebbeor JF; Connolly GC; Seward DJ; Lenth BE; Henson JH; Sundaram P; Boyer JL
    Am J Physiol Gastrointest Liver Physiol; 2000 Jan; 278(1):G57-63. PubMed ID: 10644562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased Na+-dependent taurocholate uptake and low expression of the sinusoidal Na+-taurocholate cotransporting protein (Ntcp) in livers of mdr2 P-glycoprotein-deficient mice.
    Koopen NR; Wolters H; Voshol P; Stieger B; Vonk RJ; Meier PJ; Kuipers F; Hagenbuch B
    J Hepatol; 1999 Jan; 30(1):14-21. PubMed ID: 9927146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes.
    Rippin SJ; Hagenbuch B; Meier PJ; Stieger B
    Hepatology; 2001 Apr; 33(4):776-82. PubMed ID: 11283839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
    Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Alterations of Bile Canaliculi Dynamics and the Rho Kinase/Myosin Light Chain Kinase Pathway Are Characteristics of Drug-Induced Intrahepatic Cholestasis.
    Burbank MG; Burban A; Sharanek A; Weaver RJ; Guguen-Guillouzo C; Guillouzo A
    Drug Metab Dispos; 2016 Nov; 44(11):1780-1793. PubMed ID: 27538918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of increased biliary lipid secretion in mice with genetic inactivation of bile salt export pump.
    Gooijert KE; Havinga R; Wolters H; Wang R; Ling V; Tazuma S; Verkade HJ
    Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(5):G450-7. PubMed ID: 25552583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile salt transporters: molecular characterization, function, and regulation.
    Trauner M; Boyer JL
    Physiol Rev; 2003 Apr; 83(2):633-71. PubMed ID: 12663868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatobiliary transport of bile acids and organic anions.
    Takikawa H
    J Hepatobiliary Pancreat Surg; 2002; 9(4):443-7. PubMed ID: 12483266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional expression of the canalicular bile salt export pump of human liver.
    Noé J; Stieger B; Meier PJ
    Gastroenterology; 2002 Nov; 123(5):1659-66. PubMed ID: 12404240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of hepatocellular transporters.
    Pauli-Magnus C; Meier PJ
    Pharmacogenetics; 2003 Apr; 13(4):189-98. PubMed ID: 12668915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver.
    Stieger B; Fattinger K; Madon J; Kullak-Ublick GA; Meier PJ
    Gastroenterology; 2000 Feb; 118(2):422-30. PubMed ID: 10648470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs.
    Mita S; Suzuki H; Akita H; Hayashi H; Onuki R; Hofmann AF; Sugiyama Y
    Drug Metab Dispos; 2006 Sep; 34(9):1575-81. PubMed ID: 16760228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.